VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis.

Find Full text
Thumbnail
Fulltext:
187987.pdf
Embargo:
until further notice
Size:
211.3Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2000
Author(s)
Mommers, J.M.
Rossum, M.M. van
Kooijmans-Otero, M.E.
Parker, G.L.
Kerkhof, P.C.M. van de
Number of pages
8 p.
Source
British Journal of Dermatology, 142, (2000), pp. 259-266
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/187987   https://hdl.handle.net/2066/187987
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.